Literature DB >> 29437958

Superinfection Exclusion between Two High-Risk Human Papillomavirus Types during a Coinfection.

Jennifer Biryukov1, Craig Meyers2.   

Abstract

Superinfection exclusion is a common phenomenon whereby a single cell is unable to be infected by two types of the same pathogen. Superinfection exclusion has been described for various viruses, including vaccinia virus, measles virus, hepatitis C virus, influenza A virus, and human immunodeficiency virus. Additionally, the mechanism of exclusion has been observed at various steps of the viral life cycle, including attachment, entry, viral genomic replication, transcription, and exocytosis. Human papillomavirus (HPV) is the causative agent of cervical cancer. Recent epidemiological studies indicate that up to 50% women who are HPV positive (HPV+) are infected with more than one HPV type. However, no mechanism of superinfection exclusion has ever been identified for HPV. Here, we show that superinfection exclusion exists during a HPV coinfection and that it occurs on the cell surface during the attachment/entry phase of the viral life cycle. Additionally, we are able to show that the minor capsid protein L2 plays a role in this exclusion. This study shows, for the first time, that superinfection exclusion occurs during HPV coinfections and describes a potential molecular mechanism through which it occurs.IMPORTANCE Superinfection exclusion is a phenomenon whereby one cell is unable to be infected by multiple related pathogens. This phenomenon has been described for many viruses and has been shown to occur at various points in the viral life cycle. HPV is the causative agent of cervical cancer and is involved in other anogenital and oropharyngeal cancers. Recent epidemiological research has shown that up to 50% of HPV-positive individuals harbor more than one type of HPV. We investigated the interaction between two high-risk HPV types, HPV16 and HPV18, during a coinfection. We present data showing that HPV16 is able to block or exclude HPV18 on the cell surface during a coinfection. This exclusion is due in part to differences in the HPV minor capsid protein L2. This report provides, for the first time, evidence of superinfection exclusion for HPV and leads to a better understanding of the complex interactions between multiple HPV types during coinfections.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  HPV16; HPV18; coinfection; human papillomavirus; superinfection exclusion; virus

Mesh:

Year:  2018        PMID: 29437958      PMCID: PMC5874422          DOI: 10.1128/JVI.01993-17

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  116 in total

1.  Multiplicity of infection and the evolution of hybrid incompatibility in segmented viruses.

Authors:  S A Frank
Journal:  Heredity (Edinb)       Date:  2001-11       Impact factor: 3.821

2.  Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection.

Authors:  Rebecca M Richards; Douglas R Lowy; John T Schiller; Patricia M Day
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

Review 3.  The papillomavirus major capsid protein L1.

Authors:  Christopher B Buck; Patricia M Day; Benes L Trus
Journal:  Virology       Date:  2013-06-22       Impact factor: 3.616

4.  Human papillomavirus infections with multiple types and risk of cervical neoplasia.

Authors:  Helen Trottier; Salaheddin Mahmud; Maria Cecilia Costa; João P Sobrinho; Eliane Duarte-Franco; Thomas E Rohan; Alex Ferenczy; Luisa L Villa; Eduardo L Franco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-07       Impact factor: 4.254

5.  Prevalence and clustering patterns of human papillomavirus genotypes in multiple infections.

Authors:  Anil K Chaturvedi; Leann Myers; Ansley F Hammons; Rebecca A Clark; Kathleen Dunlap; Patricia J Kissinger; Michael E Hagensee
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-10       Impact factor: 4.254

6.  Tissue-spanning redox gradient-dependent assembly of native human papillomavirus type 16 virions.

Authors:  Michael J Conway; Samina Alam; Eric J Ryndock; Linda Cruz; Neil D Christensen; Richard B S Roden; Craig Meyers
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

7.  Human papillomavirus type 31 uses a caveolin 1- and dynamin 2-mediated entry pathway for infection of human keratinocytes.

Authors:  Jessica L Smith; Samuel K Campos; Michelle A Ozbun
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

8.  Cross-neutralization potential of native human papillomavirus N-terminal L2 epitopes.

Authors:  Michael J Conway; Linda Cruz; Samina Alam; Neil David Christensen; Craig Meyers
Journal:  PLoS One       Date:  2011-02-08       Impact factor: 3.240

9.  Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells: mechanism for persistence in AIDS.

Authors:  M Stevenson; C Meier; A M Mann; N Chapman; A Wasiak
Journal:  Cell       Date:  1988-05-06       Impact factor: 66.850

Review 10.  Retroviral superinfection resistance.

Authors:  Micha Nethe; Ben Berkhout; Antoinette C van der Kuyl
Journal:  Retrovirology       Date:  2005-08-18       Impact factor: 4.602

View more
  12 in total

1.  The Matrix Protein of a Plant Rhabdovirus Mediates Superinfection Exclusion by Inhibiting Viral Transcription.

Authors:  Xin Zhou; Kai Sun; Xueping Zhou; Andrew O Jackson; Zhenghe Li
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

2.  Capturing multiple-type interactions into practical predictors of type replacement following human papillomavirus vaccination.

Authors:  Irene Man; Kari Auranen; Jacco Wallinga; Johannes A Bogaards
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-27       Impact factor: 6.237

3.  Detection and quantification of bovine papillomavirus DNA by digital droplet PCR in sheep blood.

Authors:  Sante Roperto; Anna Cutarelli; Federica Corrado; Francesca De Falco; Canio Buonavoglia
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

4.  Quantitative measurements of early alphaviral replication dynamics in single cells reveals the basis for superinfection exclusion.

Authors:  Zakary S Singer; Pradeep M Ambrose; Tal Danino; Charles M Rice
Journal:  Cell Syst       Date:  2021-01-29       Impact factor: 11.091

5.  Disease Manifestation and Viral Sequences in a Bonobo More Than 30 Years after Papillomavirus Infection.

Authors:  Markus Hoffmann; Enrika Schütze; Andreas Bernhard; Lennart Schlaphoff; Artur Kaul; Sandra Schöniger; Stefan Pöhlmann
Journal:  Pathogens       Date:  2019-01-26

6.  Selection of viral variants during persistent infection of insectivorous bat cells with Middle East respiratory syndrome coronavirus.

Authors:  Arinjay Banerjee; Sonu Subudhi; Noreen Rapin; Jocelyne Lew; Richa Jain; Darryl Falzarano; Vikram Misra
Journal:  Sci Rep       Date:  2020-04-29       Impact factor: 4.379

7.  Longitudinal assessment of nonavalent vaccine HPV types in a sample of sexually active African American women from ten U.S. Cities.

Authors:  P Madhivanan; K Krupp; M Coudray; B Colbert; D Ruiz-Perez; H Cui; N Bokulich; G Narasimhan; K Mathee; R L Cook; J Schwebke; D Roe
Journal:  Vaccine       Date:  2021-07-20       Impact factor: 4.169

8.  Clinical Significance of the Interaction between Human Papillomavirus (HPV) Type 16 and Other High-Risk Human Papillomaviruses in Women with Cervical Intraepithelial Neoplasia (CIN) and Invasive Cervical Cancer.

Authors:  Arsenio Spinillo; Mattia Dominoni; Anna C Boschi; Cecilia Sosso; Giacomo Fiandrino; Stefania Cesari; Barbara Gardella
Journal:  J Oncol       Date:  2020-10-26       Impact factor: 4.375

9.  Human Papillomavirus Genotype Replacement: Still Too Early to Tell?

Authors:  Irene Man; Simopekka Vänskä; Matti Lehtinen; Johannes A Bogaards
Journal:  J Infect Dis       Date:  2021-08-02       Impact factor: 5.226

10.  Identification of the Human Papillomavirus Genotypes, According to the Human Immunodeficiency Virus Status in a Cohort of Women from Maputo, Mozambique.

Authors:  Cremildo Maueia; Alltalents Murahwa; Alice Manjate; Soren Andersson; Jahit Sacarlal; Darlene Kenga; Tufária Mussá; Anna-Lise Williamson
Journal:  Viruses       Date:  2021-12-23       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.